Impact of policy alterations on elective percutaneous coronary interventions in Japan

Tetsuji Morishita1,2, Daisuke Takada1, Jung-Ho Shin1

  • 1Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Insights

A 2018 Japanese policy change requiring proof of ischemia significantly reduced monthly elective percutaneous coronary intervention (PCI) procedures for stable angina pectoris (SAP). Emergent PCI rates remained stable, indicating appropriate use of PCI.

Area of Science:

  • Cardiology
  • Health Policy
  • Health Economics

Background:

  • Clinical guidelines recommend documenting ischemia before elective percutaneous coronary intervention (PCI) for stable angina pectoris (SAP).
  • A 2018 Japanese reimbursement policy change mandated proof of ischemia for PCI procedures, aiming to ensure appropriate use.
  • The impact of this policy revision on PCI utilization for SAP in Japan was previously unclear.

Purpose of the Study:

  • To evaluate the effect of Japan's 2018 reimbursement policy revision on elective percutaneous coronary intervention (PCI) procedures for stable angina pectoris (SAP).
  • To assess whether the policy change influenced the appropriate utilization of PCI by examining trends in elective versus emergent procedures.

Main Methods:

  • Utilized administrative claims data from Japan's Diagnosis Procedure Combination database (April 2014–March 2020).
  • Employed interrupted time series analyses with a control group (emergent PCI) to assess the impact of the 2018 reimbursement revision.
  • Analyzed monthly trends in elective PCI procedures before and after the policy change.

Main Results:

  • A total of 773,240 PCI procedures were analyzed.
  • Following the 2018 reimbursement revision, a significant decrease in elective PCI procedures per month was observed (-106.3 procedures/month, p<0.01).
  • The number of emergent PCI procedures remained stable, suggesting the policy did not affect urgent interventions.

Conclusions:

  • The 2018 revision of the reimbursement policy in Japan led to a significant reduction in monthly elective percutaneous coronary intervention (PCI) procedures for stable angina pectoris (SAP).
  • This policy change appears to have successfully promoted more judicious use of PCI by requiring documented evidence of ischemia.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
103
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18